PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
SRTS vs. SPCB
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between SRTS and SPCB is 0.07, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

SRTS vs. SPCB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sensus Healthcare, Inc. (SRTS) and SuperCom Ltd. (SPCB). The values are adjusted to include any dividend payments, if applicable.

-50.00%0.00%50.00%100.00%150.00%200.00%250.00%300.00%SeptemberOctoberNovemberDecember2025February
-14.97%
179.31%
SRTS
SPCB

Key characteristics

Sharpe Ratio

SRTS:

0.32

SPCB:

1.31

Sortino Ratio

SRTS:

1.10

SPCB:

2.80

Omega Ratio

SRTS:

1.15

SPCB:

1.35

Calmar Ratio

SRTS:

0.35

SPCB:

1.97

Martin Ratio

SRTS:

1.57

SPCB:

4.28

Ulcer Index

SRTS:

17.51%

SPCB:

45.99%

Daily Std Dev

SRTS:

85.77%

SPCB:

150.23%

Max Drawdown

SRTS:

-87.51%

SPCB:

-99.98%

Current Drawdown

SRTS:

-63.19%

SPCB:

-99.91%

Fundamentals

Market Cap

SRTS:

$90.89M

SPCB:

$7.57M

EPS

SRTS:

$0.41

SPCB:

$21.93

PE Ratio

SRTS:

13.44

SPCB:

0.17

PEG Ratio

SRTS:

0.00

SPCB:

0.00

Total Revenue (TTM)

SRTS:

$28.74M

SPCB:

$14.40M

Gross Profit (TTM)

SRTS:

$17.33M

SPCB:

$7.53M

EBITDA (TTM)

SRTS:

$6.48M

SPCB:

$1.85M

Returns By Period

In the year-to-date period, SRTS achieves a -20.38% return, which is significantly lower than SPCB's 121.58% return.


SRTS

YTD

-20.38%

1M

-18.61%

6M

-14.97%

1Y

36.05%

5Y*

3.51%

10Y*

N/A

SPCB

YTD

121.58%

1M

-1.66%

6M

180.90%

1Y

202.89%

5Y*

-38.83%

10Y*

-39.67%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

SRTS vs. SPCB — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SRTS
The Risk-Adjusted Performance Rank of SRTS is 6060
Overall Rank
The Sharpe Ratio Rank of SRTS is 5757
Sharpe Ratio Rank
The Sortino Ratio Rank of SRTS is 6060
Sortino Ratio Rank
The Omega Ratio Rank of SRTS is 6060
Omega Ratio Rank
The Calmar Ratio Rank of SRTS is 6161
Calmar Ratio Rank
The Martin Ratio Rank of SRTS is 6262
Martin Ratio Rank

SPCB
The Risk-Adjusted Performance Rank of SPCB is 8585
Overall Rank
The Sharpe Ratio Rank of SPCB is 8383
Sharpe Ratio Rank
The Sortino Ratio Rank of SPCB is 8989
Sortino Ratio Rank
The Omega Ratio Rank of SPCB is 8686
Omega Ratio Rank
The Calmar Ratio Rank of SPCB is 9090
Calmar Ratio Rank
The Martin Ratio Rank of SPCB is 7777
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

SRTS vs. SPCB - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Sensus Healthcare, Inc. (SRTS) and SuperCom Ltd. (SPCB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for SRTS, currently valued at 0.32, compared to the broader market-2.000.002.004.000.321.31
The chart of Sortino ratio for SRTS, currently valued at 1.10, compared to the broader market-6.00-4.00-2.000.002.004.006.001.102.80
The chart of Omega ratio for SRTS, currently valued at 1.15, compared to the broader market0.501.001.502.001.151.35
The chart of Calmar ratio for SRTS, currently valued at 0.35, compared to the broader market0.002.004.006.000.351.97
The chart of Martin ratio for SRTS, currently valued at 1.57, compared to the broader market-10.000.0010.0020.0030.001.574.28
SRTS
SPCB

The current SRTS Sharpe Ratio is 0.32, which is lower than the SPCB Sharpe Ratio of 1.31. The chart below compares the historical Sharpe Ratios of SRTS and SPCB, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00SeptemberOctoberNovemberDecember2025February
0.32
1.31
SRTS
SPCB

Dividends

SRTS vs. SPCB - Dividend Comparison

Neither SRTS nor SPCB has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

SRTS vs. SPCB - Drawdown Comparison

The maximum SRTS drawdown since its inception was -87.51%, smaller than the maximum SPCB drawdown of -99.98%. Use the drawdown chart below to compare losses from any high point for SRTS and SPCB. For additional features, visit the drawdowns tool.


-100.00%-90.00%-80.00%-70.00%-60.00%-50.00%-40.00%SeptemberOctoberNovemberDecember2025February
-63.19%
-98.78%
SRTS
SPCB

Volatility

SRTS vs. SPCB - Volatility Comparison

Sensus Healthcare, Inc. (SRTS) and SuperCom Ltd. (SPCB) have volatilities of 46.31% and 45.88%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%SeptemberOctoberNovemberDecember2025February
46.31%
45.88%
SRTS
SPCB

Financials

SRTS vs. SPCB - Financials Comparison

This section allows you to compare key financial metrics between Sensus Healthcare, Inc. and SuperCom Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab